Clinical Research Strategies is a US-owned and operated, clinical CRO and executive management consultancy for start-up and mid-size life sciences companies. We help instill fiscal discipline and reduce risks in clinical development, corporate affairs, and quality assurance programs as a strategic extension of your team. Project-specific, fit-for-purpose, ad hoc consulting, and staffing clinical trials is what we do best, whatever stage your program is in. CRS advisors have been everywhere – clinical research organizations, life science start-ups, and large pharma and medical device companies. We can help you manage and overcome complicated trial operations and the burdensome regulatory pathways to a successful product launch. Our specialties include: novel medical products, federal grants, regulatory strategy, regenerative medicine, immuno-oncology, infectious diseases, critical care, orthopedics, respiratory, imaging, CNS, precision medicine, reproductive medicine, cannabinoids, digital therapeutics, SaMD/medical devices, EU MDR, rescue trials, and much more.
Visit our website: www.clinicalresearchstrategies.com.